NUR 557 Module 8 Case Paper Example

Silent Bacteria, Two Patients: Treating Asymptomatic Bacteriuria at 14 Weeks of Pregnancy

[Student Name]

Southern New Hampshire University

NUR 557: Advanced Pathophysiology and Pharmacology Across the Lifespan

Case Paper

[Instructor Name]

[Date]

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

Silent Bacteria, Two Patients: Treating Asymptomatic Bacteriuria at 14 Weeks of Pregnancy

Bacteria in the urine without symptoms, asymptomatic bacteriuria, is usually harmless and usually not treated. Pregnancy is the major exception. The Infectious Diseases Society of America recommends screening pregnant women with a urine culture early in pregnancy and treating bacteriuria when it is found (Nicolle et al., 2019). This paper explains why, using a composite patient at 14 weeks. It argues that the physiology of pregnancy converts a benign finding into a real risk of kidney infection and preterm birth, and that choosing the antibiotic means matching the organism's susceptibility with the drug's safety at her stage of pregnancy, then adjusting for pregnancy's faster clearance.

The Case

The patient is 24, in her first pregnancy and 14 weeks pregnant. At her first prenatal visit she had a routine urine culture, which grew more than 100,000 colony-forming units per milliliter of Escherichia coli. She has no burning, frequency, urgency, fever or flank pain. The organism is susceptible to cephalexin, nitrofurantoin and fosfomycin, and resistant to ampicillin and to trimethoprim-sulfamethoxazole. She has no drug allergies and normal kidney function.

Why Pregnancy Changes the Risk

Several changes of pregnancy make bacteria in the bladder more likely to climb to the kidneys. Progesterone relaxes smooth muscle, including the ureters, which dilate and move urine more slowly, and the enlarging uterus compresses the ureters, particularly on the right. The bladder's tone and capacity change, leaving more residual urine. Increased kidney filtration can allow small amounts of glucose and amino acids into the urine, which bacteria can use for growth (Rosenthal & Burchum, 2021). Together, stasis and dilation give E. coli, which already carries fimbriae that help it attach to urinary tract cells, an easier path upward.

The consequences justify screening. Untreated bacteriuria in pregnancy is associated with a substantially higher risk of pyelonephritis, and pyelonephritis in pregnancy can cause sepsis and is associated with preterm birth and low birth weight; treating bacteriuria reduces the risk of pyelonephritis (Nicolle et al., 2019). For this patient, the absence of symptoms reflects the stage of infection, not its harmlessness.

Choosing the Antibiotic

The drug must kill her organism, reach high levels in the urine and be safe for a fetus at 14 weeks. Table 1 compares the options her culture allows and those it rules out.

Table 1

Antibiotic Options by Mechanism, Susceptibility and Pregnancy Safety

Cephalexin is the best fit. Her organism is susceptible, the drug concentrates in the urine and beta-lactams have long been used in pregnancy without evidence of fetal harm. Nitrofurantoin is a reasonable alternative now that she is past the first trimester; professional guidance supports its use in the second and third trimesters and reserves first-trimester use for when no suitable alternative exists (American College of Obstetricians and Gynecologists, 2017). Trimethoprim-sulfamethoxazole is excluded twice, by resistance and by its folate antagonism, and fluoroquinolones and tetracyclines are generally avoided in pregnancy. Guidelines suggest a short course, commonly four to seven days, rather than the longer courses once used (Nicolle et al., 2019).

How Cephalexin Kills the Organism

Cephalexin, a first-generation cephalosporin, binds penicillin-binding proteins, the enzymes that cross-link peptidoglycan in the bacterial cell wall. Without those cross-links, the wall weakens as the bacterium grows, and the cell bursts under its own internal pressure. The drug therefore kills bacteria that are actively dividing, which is why steady levels over the full course matter. Because human cells have no cell wall, the target does not exist in mother or fetus, which is one reason beta-lactams are so well tolerated in pregnancy (Rosenthal & Burchum, 2021). Her organism's resistance to ampicillin, most likely from a beta-lactamase enzyme, did not extend to cephalexin, as the culture confirmed; that pattern is why the susceptibility report, not the drug class alone, decides the choice.

Pregnancy Pharmacokinetics

Pregnancy changes how the body handles drugs. Kidney blood flow and glomerular filtration rise by roughly half, so drugs cleared by the kidneys, including cephalexin, are removed faster, and plasma volume expands, increasing the volume of distribution (Rosenthal & Burchum, 2021). For cephalexin, this means doses should be given on schedule rather than stretched, and standard adult dosing is used rather than reduced; the drug's high urinary concentration still exceeds what is needed to kill a susceptible organism. The same physiology explains why renally cleared drugs used in pregnancy for chronic conditions sometimes need dose increases as pregnancy advances.

Follow-Up and Teaching

She should take every dose even though she feels well, since stopping early risks leaving bacteria in the urinary tract. She is taught the signs of pyelonephritis, fever, chills, flank pain and vomiting, and told to seek care the same day if they occur. Because bacteriuria can recur during pregnancy, many clinicians repeat a urine culture after treatment and periodically during the rest of the pregnancy. Adequate fluid intake and not delaying voiding are reasonable supportive measures. If bacteriuria returns repeatedly, suppressive antibiotic therapy for the remainder of pregnancy may be considered.

Conclusion

This patient's silent bacteriuria matters because pregnancy has widened and slowed her urinary tract, giving E. coli an easier route to the kidneys, where infection could threaten both her and her pregnancy. Cephalexin fits because it kills her organism, concentrates in urine and has a long safety record in pregnancy, while nitrofurantoin is a reasonable second choice at 14 weeks and trimethoprim-sulfamethoxazole is ruled out twice over. Pregnancy's faster kidney clearance shapes how the drug is taken, and follow-up cultures guard against recurrence.

References

American College of Obstetricians and Gynecologists. (2017). Sulfonamides, nitrofurantoin, and risk of birth defects (Committee Opinion No. 717). Obstetrics & Gynecology, 130(3), e150-e152.

Nicolle, L. E., Gupta, K., Bradley, S. F., Colgan, R., DeMuri, G. P., Drekonja, D., Eckert, L. O., Geerlings, S. E., Köves, B., Hooton, T. M., Juthani-Mehta, M., Knight, S. L., Saint, S., Schaeffer, A. J., Trautner, B., Wullt, B., & Siemieniuk, R. (2019). Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 68(10), e83-e110. https://doi.org/10.1093/cid/ciy1121

Rosenthal, L. D., & Burchum, J. R. (2021). Lehne's pharmacotherapeutics for advanced practice nurses and physician associates (2nd ed.). Elsevier.